Results 21 to 30 of about 6,798 (212)

Designing a Humanized Immunotoxin Based on HER2 Specific scFv and DFF40 Toxin Against Breast Cancer: An In-Silico Study

open access: yes, 2022
Breast cancer is the most frequent cancer in women worldwide. Human epidermal growth factor receptor 2 (HER2) is a receptor which is overexpressed in breast cancer cells.
Ahmadi, Khadijeh   +21 more
core   +1 more source

Crotamine-based recombinant immunotoxin targeting HER2 for enhanced cancer cell specificity and cytotoxicity

open access: yes, 2023
Crotamine, one of the major toxins present in the venom of the South American rattlesnake Crotalus durissus terrificus, exhibits potent cytotoxic properties and has been suggested for cancer therapy applications. However, its selectivity for cancer cells
Minh Quan Nguyen   +8 more
core   +1 more source

Immunotoxins for leukemia

open access: yesBlood, 2014
AbstractUnconjugated monoclonal antibodies that target hematopoietic differentiation antigens have been developed to treat hematologic malignancies. Although some of these have activity against chronic lymphocytic leukemia and hairy cell leukemia, in general, monoclonal antibodies have limited efficacy as single agents in the treatment of leukemia.
Alan S, Wayne   +3 more
openaire   +3 more sources

Optimization of the Refolding Process for Recombinant Anti-EGFR Immunotoxin Produced in the Escherichia coli

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, 2021
Introduction: Overexpression of the EGFR is associated with carcinogenesis, and it is observed in more than 70% of head and neck cancers. The expression of an immunotoxin against EGFR designed as an alternative to full antibody led to the production of ...
Bahman Akbari
doaj  

Treatment with immunotoxin [PDF]

open access: yesPhilosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 2001
T–cell depletion prior to or beginning at the time of transplantation has been shown to be a valuable adjunct to the induction of immunological unresponsiveness. Both total lymphoid irradiation and anti–lymphocyte globulin have been used for this purpose in experimental models of transplantation as well as in human organ transplant
openaire   +2 more sources

Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin

open access: yesCell Transplantation, 2015
Depletion of alloreactive T-lymphocytes from allogeneic bone marrow tansplants may prevent graft-versus-host disease (GVHD) without impairing donor cell engraftment, immunity, and the graft-versus-leukemia (GVL) effect.
Sang C. Lee   +8 more
doaj   +1 more source

Bacteria-derived chimeric toxins as potential anticancer agents

open access: yesFrontiers in Oncology, 2022
Cancer is one of the major causes of death globally, requiring everlasting efforts to develop novel, specific, effective, and safe treatment strategies.
Saeed Khoshnood   +7 more
doaj   +1 more source

Mab-Zap: A Tool for Evaluating Antibody Efficacy for Use in an Immunotoxin

open access: yesBioTechniques, 2000
Immunotoxins, consisting of antibodies coupled to toxins, are extremely useful tools in the elimination of specific cell populations in vitro and in vivo for research and therapeutic applications.
Matthew D. Kohls, Douglas A. Lappi
doaj   +1 more source

Immunotoxins: The Role of the Toxin [PDF]

open access: yesToxins, 2013
Immunotoxins are antibody-toxin bifunctional molecules that rely on intracellular toxin action to kill target cells. Target specificity is determined via the binding attributes of the chosen antibody. Mostly, but not exclusively, immunotoxins are purpose-built to kill cancer cells as part of novel treatment approaches.
David FitzGerald, Antonella Antignani
openaire   +3 more sources

Kinetic events involved in immunotoxin-antigen binding and intracellular trafficking.

open access: yes, 2014
Each yellow arrow indicates a kinetic step of the model. The tumor cell sheds the surface antigen and the surface complexed antigen at a certain rate. The immunotoxin molecule exiting from the capillary diffuses in the extra-cellular space and binds to ...
Robert J. Kreitman (649284)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy